Europe Tendonitis Treatment Market Size & Outlook

The tendonitis treatment market in Europe is expected to reach a projected revenue of US$ 88,371.2 million by 2030. A compound annual growth rate of 3.9% is expected of Europe tendonitis treatment market from 2023 to 2030.

Revenue, 2022 (US$M)
$64,870.3
Forecast, 2030 (US$M)
$88,371.2
CAGR, 2023 - 2030
3.9%
Report Coverage
Europe

Europe tendonitis treatment market highlights

  • The Europe tendonitis treatment market generated a revenue of USD 64,870.3 million in 2022.
  • The market is expected to grow at a CAGR of 3.9% from 2023 to 2030.
  • In terms of segment, therapy was the largest revenue generating treatment in 2022.
  • Surgery is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2023 to 2030.

Europe data book summary

Market revenue in 2022USD 64,870.3 million
Market revenue in 2030USD 88,371.2 million
Growth rate3.9% (CAGR from 2022 to 2030)
Largest segmentTherapy
Fastest growing segmentSurgery
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTherapy, Surgery
Key market players worldwideMerck & Co Inc, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Pfizer Inc, GSK PLC, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim Pharma, Almatica Pharma

Other key industry trends

  • In terms of revenue, Europe region accounted for 30.9% of the global tendonitis treatment market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 49,314.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Tendonitis Treatment Market Companies

Name Profile # Employees HQ Website

Europe tendonitis treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tendonitis treatment market will help companies and investors design strategic landscapes.


Therapy was the largest segment with a revenue share of 85.12% in 2022. Horizon Databook has segmented the Europe tendonitis treatment market based on therapy, surgery covering the revenue growth of each sub-segment from 2018 to 2030.


  • Europe Tendonitis Treatment Treatment Outlook (Revenue, USD Million, 2018-2030)
    • Therapy
      • Hot and Cold Therapy
      • Physical Therapy
      • Shockwave Therapy
    • Surgery
  • Europe Tendonitis Treatment Condition Outlook (Revenue, USD Million, 2018-2030)
    • Tennis Elbow
    • Golfer’s Elbow
    • Pitcher’s Elbow
    • Jumper’s Knee
    • Swimmer’s Shoulder
    • Achilles Tendonitis

Reasons to subscribe to Europe tendonitis treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe tendonitis treatment market databook

  • Our clientele includes a mix of tendonitis treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe tendonitis treatment market, including forecasts for subscribers. This continent databook contains high-level insights into Europe tendonitis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe tendonitis treatment market report size, by country, 2018-2030 (US$M)

Europe Tendonitis Treatment Market Share, 2022 & 2030 (US$M)

Europe tendonitis treatment market report size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more